These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 1438435

  • 1. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
    Champlin R, Giralt S, Przepiorka D, Ho W, Lee K, Gajewski J, Nimer S, Andersson B, Wallerstein R, Ippolito C.
    Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
    [No Abstract] [Full Text] [Related]

  • 2. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
    Champlin R, Jansen J, Ho W, Gajewski J, Nimer S, Lee K, Territo M, Winston D, Tricot G, Reichert T.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1695-6. PubMed ID: 1899162
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D, García-López J, Sureda A, Canals C, Ferra C, Cancelas JA, Berlanga JJ, Brunet S, Boqué C, Picón M, Torrico C, Amill B, Martino R, Martínez C, Martín-Henao G, Domingo-Albós A, Grañena A.
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [Abstract] [Full Text] [Related]

  • 4. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
    Jansen J, Hanks S, English D, Karaffa R, Akard L.
    Prog Clin Biol Res; 1992 Dec; 377():405-10. PubMed ID: 1438437
    [No Abstract] [Full Text] [Related]

  • 5. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE.
    J Immunol; 1996 Dec 01; 157(11):4811-21. PubMed ID: 8943383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Italian survey on allogeneic BMT for chronic myeloid leukaemia.
    Arcese W, Mandelli F, Papa G, Bacigalupo A, Van Lint MT, Lucarelli G, Galimberti P, Polchi P, Tura S, Bandini G.
    Bone Marrow Transplant; 1989 Dec 01; 4 Suppl 4():90-1. PubMed ID: 2697445
    [No Abstract] [Full Text] [Related]

  • 9. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.
    Jiang YZ, Mavroudis DA, Dermime S, Molldrem J, Hensel NF, Barrett AJ.
    Bone Marrow Transplant; 1997 May 01; 19(9):899-903. PubMed ID: 9156263
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E, Nagler A, Or R, Kapelushnik J, Slavin S.
    Clin Transpl; 1996 May 01; ():281-90. PubMed ID: 9286578
    [Abstract] [Full Text] [Related]

  • 11. Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Jansen J, Hanks S, Akard L, Martin M, Thompson J, Chang Q, Ash R, Garrett P, Figg F, English D.
    Bone Marrow Transplant; 1995 Feb 01; 15(2):271-8. PubMed ID: 7773217
    [Abstract] [Full Text] [Related]

  • 12. Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation.
    Champlin R, Gajewski J, Feig S, Giorgi J, Lyddane N, Lee K, Schmidt I, Winston D, Ho W, Reichert T.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 3):2947-8. PubMed ID: 2495694
    [No Abstract] [Full Text] [Related]

  • 13. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J, Mahé B, Milpied N, Devilder MC, Dréno B, Bignon JD, Davodeau F, Hallet MM, Bonneville M, Vié H.
    J Clin Invest; 1993 Jan 01; 91(1):12-20. PubMed ID: 8423212
    [Abstract] [Full Text] [Related]

  • 14. Graft-versus-leukemia reactions following bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S.
    Prog Clin Biol Res; 1992 Jan 01; 377():113-25; discussion 126-7. PubMed ID: 1438407
    [No Abstract] [Full Text] [Related]

  • 15. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
    Champlin R.
    Semin Hematol; 1992 Jul 01; 29(3 Suppl 2):46-52. PubMed ID: 1509294
    [No Abstract] [Full Text] [Related]

  • 16. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL, Atasoylu AA.
    Bone Marrow Transplant; 1991 Jul 01; 8(1):51-8. PubMed ID: 1833016
    [Abstract] [Full Text] [Related]

  • 17. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
    Schumm M, Kolb HJ, Hahn J, Beisser K, Rieber P, Günther W, Büttner M, Wilmanns W, Thierfelder S.
    Prog Clin Biol Res; 1992 Jul 01; 377():419-25. PubMed ID: 1438440
    [No Abstract] [Full Text] [Related]

  • 18. A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
    Henslee PJ, Byers VS, Jennings CD, Marciniak E, Thompson JS, Macdonald JS, Romond EH, Messino MJ, Scannon PJ.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 3):3004-7. PubMed ID: 2650413
    [No Abstract] [Full Text] [Related]

  • 19. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
    Bishop MR, Henslee-Downey PJ, Anderson JR, Romond EH, Marciniak E, Yankey R, Reeves M, Thompson JS.
    Bone Marrow Transplant; 1996 Oct 01; 18(4):747-53. PubMed ID: 8899190
    [Abstract] [Full Text] [Related]

  • 20. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B, Bogunia-Kubik K, Dlubek D, Jaskula E, Sok A, Drabczak-Skrzypek D, Sedzimirska M, Lange A.
    Transplant Proc; 2007 Nov 01; 39(9):2898-901. PubMed ID: 18022011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.